ask="42.30"
ask_size="100"
average_daily_volume="1579740"
bid="41.28"
bid_size="200"
book_value="11.83"
change="-0.24"
change_from_200_day_moving_average="-14.22"
change_from_50_day_moving_average="-0.92"
change_from_52_week_high="-41.82"
change_From_52_week_low="10.22"
change_in_percent="-0.57%"
close="41.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.80"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="70877000"
high="43.39"
high_52_weeks="83.42"
last_trade_date="1/13/2017"
last_trade_price="41.60"
last_trade_size="100371"
last_trade_time="4:00pm"
low="41.32"
low_52_weeks="31.38"
market_capitalization="3.57B"
moving_average_200_day="55.82"
moving_average_50_day="42.52"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="63.36"
open="41.81"
pe_ratio="N/A"
peg_ratio="-0.20"
percent_change_from_200_day_moving_average="-25.47%"
percent_change_from_50_day_moving_average="-2.17%"
percent_change_from_52_week_high="-50.13%"
percent_change_from_52_week_low="+32.57%"
previous_close="41.84"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.54"
price_per_sales="96.37"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="5.52"
stock_exchange="NMS"
symbol="ALNY"
volume="1030720"
weeks_range_52="31.38 - 83.42"
